Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

Clinical trial NCT06277050 · RECRUITING

Trial details

NCT number: NCT06277050
Sponsor: Jiangxi Provincial Cancer Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma High-Risk Cancer Maintenance Therapy

Start date: 2024-03-07
Primary completion: 2030-02-20
Enrollment: 264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.